UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044783
Receipt number R000051150
Scientific Title Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial
Date of disclosure of the study information 2021/07/31
Last modified on 2021/07/07 14:27:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Acronym

Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Scientific Title

Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Scientific Title:Acronym

Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Region

Japan


Condition

Condition

ESRD

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Non-tunneled temporary hemodialysis catheter (NTHC) is required for urgent dialysis. Either one of single lumen catheter or double lumen catheter is used, but it is not inspected which one is more useful. We will compare safety, effectiveness, cost-benefit between these.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

incidence of blood removal failure in the six dialysis sessions after temporary catheter insertion

Key secondary outcomes

safety
cost-effectiveness
dialysis efficiency
abnormal test value


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Use of single lumen catheter in the six dialysis sessions

Interventions/Control_2

Use of double lumen catheter in the six dialysis sessions

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with end-stage renal disease who need blood purification therapy even temporarily and the doctor has determined that a non-cuff catheter needs to be inserted into the right internal jugular vein.
(2) Of the above, patients who are expected to undergo hemodialysis for at least 2 weeks (6 times in total) after insertion.
(3) Patients who have obtained written consent.
(4) Adult patients.

Key exclusion criteria

(1) Patients with a catheter inserted in the intensive care unit.
(2) Patients with severe congestive heart failure who require oxygen administration.
(3) Patients whose doctor has determined that it is necessary to insert a lumen catheter that exceeds the double lumen.
(4) Patients who the doctor has determined that a catheter needs to be inserted into a blood vessel other than the right internal jugular vein.
(5) Patients who undergo special blood purification therapy such as plasma exchange.
(6) Patients with infection.
(7) Patients with cancer cachexia.
(8) Patients with known coagulation abnormalities.
(9) Patients who are using anticoagulants other than undifferentiated heparin and low molecular weight heparin during hemodialysis.
(10) Patients with hybrid hemodialysis who perform peritoneal dialysis and weekly hemodialysis.
(11) Other patients who the doctor in charge judged inappropriate to participate in this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name Otsuka

Organization

Niigata University Medical and Dental Hospital

Division name

Divison of nephrology and rheumatology

Zip code

951-8510

Address

Asahimachidori1-757 chuouku Niigata city Niigata prefecture

TEL

025-227-2200

Email

totogoal1230@gmail.com


Public contact

Name of contact person

1st name Tadashi
Middle name
Last name Otsuka

Organization

Niigata University Medical and Dental Hospital

Division name

Divison of nephrology and rheumatology

Zip code

951-8510

Address

Asahimachidori1-757 chuouku Niigata city Niigata prefecture

TEL

025-227-2200

Homepage URL


Email

totogoal1230@gmail.com


Sponsor or person

Institute

Niigata Universtiy

Institute

Department

Personal name



Funding Source

Organization

Divison of nephrology and rheumatology , Niigata University Medical and Dental Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagaoka chuo hospital
Tachikawa general hospital
Jyouetsu general hospital
Sado general hospital
Uonuma institute of community hospital
Ojiya sougou hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University Ethics Committee

Address

Asahimachidori1-757 chuouku Niigata city Niigata prefecture

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長岡中央綜合病院(新潟県)
立川総合病院(新潟県)
上越総合病院(新潟県)
佐渡総合病院(新潟県)
魚沼基幹病院(新潟県)
小千谷総合病院(新潟県)


Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 11 Day

Date of IRB

2021 Year 03 Month 12 Day

Anticipated trial start date

2021 Year 08 Month 01 Day

Last follow-up date

2022 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 07 Month 07 Day

Last modified on

2021 Year 07 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051150